Abstract: This disclosure relates to techniques for signaling a quasi-colocation (QCL) update in a wireless communication system. A network or base station may indicate to a UE to change a spatial relationship for transmission/reception. The base station may provide aperiodic reference signals for the UE to use in beam tracking according to the new spatial relationship. Optionally, the base station may also provide aperiodic reference signals for time, frequency, and/or phase tracking. Thus, the network may configure the UE to change to the new spatial relationship and use the aperiodic reference signals to quickly complete initial tracking operations.

Abstract: The present invention provides methods for treating or ameliorating metabolic diseases, cholestatic liver diseases, or organ fibrosis, which comprises administering to a subject a therapeutically effective amount of a pharmaceutical composition comprising an isoxazole derivative, a racemate, an enantiomer, or a diastereoisomer thereof, or a pharmaceutically acceptable salt of the derivative, the racemate, the enantiomer, or the diastereoisomer.

Abstract: The invention relates to a T cell receptor (TCR) which is HIV-1 specific and HLA-E restricted. Particularly, the TCR is capable of binding to a peptide of RMYSPTSIL or a peptide of RMYSPTSIL in complex with HLA-E, or a peptide of ILVESPAVL or a peptide of ILVESPAVL in complex with HLA-E. The invention also relates to a nucleic acids and vector encoding the TCR.

Abstract: A lithium-based battery including an electrolyte having at least two lithium salts selected from LiPF6, LiTFSI, LiFSI or LiBF4, along with a further lithium salt additive. Through the selection of particular lithium salt combinations, a high lithium ion concentration in the electrolyte is maintained. The battery includes a cathode, an anode, and a porous polymer separator. The lithium-based battery has reliable capacity retention at high discharge rates, such as 10C to 15C.

Abstract: Methods and compositions for treating subterranean formations with fluids containing superabsorbent polymer particles are provided. In one embodiment, the methods comprise introducing a treatment fluid into a well bore penetrating at least a portion of a subterranean formation, the treatment fluid including an aqueous base fluid, and one or more superabsorbent polymer particles comprising a plurality of monomers and one or more crosslinkers wherein at least one crosslinker is a labile crosslinker.

Abstract: The present disclosure relates to a liquid crystal polyester resin composition and an electronic component material comprising the same with low dust characteristics. Specifically, the present disclosure relates to a liquid crystal polyester resin composition for preventing dust generation comprising 65% by weight or more and 85% by weight or less of a liquid crystal polyester resin; more than 0.5% by weight and less than 10% by weight of a transition metal compound containing a Group 6 element of the periodic table; 2% by weight or more and 10% by weight or less of a barium compound; 2% by weight or more and 10% by weight or less of an organic filler; and 12% by weight or more and 30% by weight or less of a filler.

Abstract: The present invention relates to monoclonal antibodies that specifically bind to human pituitary adenylate cyclase activating polypeptide (PACAP) and pharmaceutical compositions comprising such antibodies. Methods of treating or preventing headache conditions, such as migraine and cluster headache, using the monoclonal antibodies are also described.

Abstract: The present invention relates to a method for preparing a tropical fish feed by using brine shrimp, and a tropical fish feed prepared thereby, and, more specifically, to: a method for preparing a tropical fish feed by using brine shrimp, and a tropical fish feed prepared thereby, the method feeding spirulina and Haematococcus to hatched brine shrimp to prepare a tropical fish feed, and thus can promote the growth of tropical fish, boost the immune system and improve the consumption, digestion, absorption and palatability for tropical fish.

Abstract: A refrigerator incudes a refrigerating case constituting a refrigerator compartment; and a refrigerator compartment cold air supply duct disposed in a rear surface of the refrigerating case, spaced apart from one lateral surface and the other lateral surface of the refrigerating case. The refrigerator compartment cold air supply duct may include a pair of lighting units disposed along both sides of the rear surface, and the pair of lighting units may be disposed to face the lateral surface and the other lateral surface of the refrigerating case, respectively.

Abstract: The present invention relates to an anti-adhesion polymer composition. The anti-adhesion polymer composition according to the present invention has excellent adhesion performance so as to be continuously attached successfully to a wound site generated during surgery while also effectively exhibiting an anti-adhesion function, has antibacterial and hemostatic properties, and has excellent formulation stability.

Abstract: The present invention relates to the field of pharmacogenomics, which applies one or more genomic biomarkers and the related diagnostic methods, devices, reagents, systems, and kits, for predicting varied individual responses such as, for example, efficacy or adverse effect, to therapeutic agents, e.g., inhibitors of certain neurotransmitter transporters such as liafensine.

Abstract: Treatment fluids and associated methods for treating a subterranean formation. An example method includes introducing a treatment fluid into a wellbore penetrating the subterranean formation. The treatment fluid includes a competitive metal binder selected from the group consisting of polyamino polyether methylene phosphonic acid, hydoxyethylamino-di(methylene phosphonic acid), and a combination thereof; a polymer capable of forming a polymer-metal complex; and an aqueous fluid. The method further includes contacting a metal ion with the treatment fluid after introduction of the treatment fluid into the wellbore and binding the metal ion with the competitive metal binder.

Abstract: The present invention describes biomarkers that have been discovered to correlate with varied individual responses (e.g., efficacy, adverse effect, and other end points) to enzastaurin, in treating diseases such as, DLBCL, GBM, and other cancer types. The newly discovered biomarkers and others in linkage disequilibrium with them can be used in companion diagnostic tests which can help to predict drug responses and apply drugs only to those who will be benefited, or exclude those who might not be beneficial, by the treatment.

Abstract: An electrochemical device includes electrode plates and a separation layer formed on a surface of an electrode plate. The separation layer includes a porous layer formed on the surface of the electrode plate. The porous layer includes nanofibers. It takes 15 seconds or less for an electrolytic solution to infiltrate into the separation layer. The separation layer exhibits functions of a separator. Therefore, the electrochemical device achieves at least a relatively high energy density without using a stand-alone separator.

Abstract: The present invention relates to methods of migraine prophylaxis using anti-CGRP receptor antibodies or binding fragments. In particular, methods for preventing or reducing the occurrence of migraine headache in a patient in need thereof comprising administering to the patient an anti-CGRP receptor or binding fragment according to specific dosage regimens are disclosed. Pharmaceutical compositions and administration devices comprising anti-CGRP receptor antibodies or binding fragments for use in the methods are also described.

Abstract: The disclosed invention relates to a low-dose celecoxib oral formulation, and a preparation method therefor, which is characterized in that the strength of the formulation is 60-90% of the original strength of the commercial celecoxib product, and the celecoxib formulation with such reduced strength is bioequivalent to the commercial celecoxib product. The celecoxib formulation can be used for the treatment of mild to moderate pain and mild to moderate chronic pain.

Abstract: Methods for treating a subterranean formation. An example method includes introducing a treatment fluid into a wellbore penetrating the subterranean formation. The treatment fluid includes an aqueous base fluid, a cationic or amphoteric friction reducer, and a substituted alkanolamine scale inhibitor. The method further includes contacting scale deposits on a surface in fluid communication with the wellbore and/or subterranean formation with the treatment fluid.

Abstract: The present invention relates to methods of migraine prophylaxis using anti-CGRP receptor antibodies or binding fragments. In particular, methods for preventing or reducing the occurrence of migraine headache in a patient in need thereof comprising administering to the patient an anti-CGRP receptor or binding fragment according to specific dosage regimens are disclosed. Pharmaceutical compositions and administration devices comprising anti-CGRP receptor antibodies or binding fragments for use in the methods are also described.

Abstract: The present invention describes biomarkers that have been discovered to correlate with varied individual responses (e.g., efficacy, adverse effect, and other end points) to enzastaurin, in treating diseases such as, DLBCL, GBM, and other cancer types. The newly discovered biomarkers and others in linkage disequilibrium with them can be used in companion diagnostic tests which can help to predict drug responses and apply drugs only to those who will be benefited, or exclude those who might not be beneficial, by the treatment.

Abstract: The present invention relates to an online sharing system for a warrant to receive and a sharing method of receivable right, which can issue digital warrants with respect to the corresponding right by separating just the right to receive royalty to be receivable in the future, namely, a receivable right of royalty in connection with sales or business profits, depending on a rightful person's exercise of intangible assets or intellectual property right without dividing the corresponding property right or registering joint ownership of the corresponding property right to a holder of intellectual property rights, such as patent rights, trademark rights and copyrights, or a holder of franchise values, fishing rights, mining rights, and so on which belong to intangible assets, issue dedicated electronic money so that issuers and buyers can conveniently trade them in one-to-one exchange with currencies of wanted countries, let transaction participants share their shares of receivable right by a method to limit the